Zina Affas Besse
Deputy Head Healthcare Private Equity, AXA Investment Managers
Dr Zina Affas Besse has been investing in and operating healthcare companies globally for more than twenty-five years. Zina joined AXA IM Alts, global leader in alternative investments, as Deputy Head of Healthcare Private Equity in 2022 after advising AXA IM Alts since April 2020. Dr Affas Besse has been serving as Board Member for companies including Limmatech, Axena Health, Eyenuk, Biolinq, and Alydia Health (Acquired by Organon (NYSE: OGN)). Dr Zina Affas Besse earned a PhD in Medicinal Chemistry (specialising in infectious diseases) and Pharmacy degrees from The University of Nottingham.